• Report Description
  • Table Of Content
  • Request Methodology

KD Market Insights added a title on “Orphan Drugs Market – 2019-2024” to its collection of industry research reports that offers extensive and highly detailed current and future market trends in the global and regional/market. The report includes market size, Y-O-Y growth analysis and structure of the overall industry based on a unique combination of industry research, fieldwork, market sizing analysis, and our in-house expertise.

The market research report demonstrates market dynamics which includes growth drivers, restraining factors and opportunities and trends spearheading current Product Type and future status of this market. Our general approach is to target several individuals with specific questions that we believed would satisfy our research objective. Further, to speed up the data collection process, we employed an online survey, delivered via email. The research team analyzed the results to identify potential opportunities and risks for the market.

In addition, the report offers recent industry activities and value chain analysis for the Orphan Drugs Market. Moreover, Porter’s Five Forces analysis demonstrates the five forces which include buyers bargaining power, suppliers bargaining power, the threat of new entrants, the threat of substitutes, and degree of competition in Orphan Drugs Market. Along with figures and tables, a market attractiveness and BPS analysis has been provided for every segment in the report.

Global Orphan Drugs Market Size & Forecast:

Global Orphan Drugs market witnessed a market value of USD XX Million in 2019 and is estimated to reach USD XX million in 2024, registering a compound annual growth rate (CAGR) of XX% between 2019 and 2024. The report analyses the market by geographies i.e. North America, Europe, Asia Pacific, Latin America & Middle East & Africa. Further, the geographies are fragmented into the country and regional groupings:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Global Orphan Drugs Market Segmentation:-
The research offers a comprehensive analysis of global Orphan Drugs market with respect to following sub-markets:

Based on Disease Type:
- Hematologic and Immunologic diseases
- Infectious diseases
- Metabolic diseases
- Neurologic diseases
- Oncologic diseases
- Other orphan diseases

Based on Product Type:
- Biological orphan drugs
- Non-biological orphan drugs

Global Orphan Drugs Market: Competitive Landscape

The report also highlights the competitive landscape of the global Orphan Drugs market, market share and positioning of all the major players in the industry. The competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as company overview, financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, Technology development, research & development and other market activities).

The report includes profiles of leading companies in the global Orphan Drugs market.

Some of the key players profiled include:

- Actelion Pharmaceuticals Ltd.
- Amgen
- Alexion Pharmaceuticals
- Baxter international
- Bayer healthcare pharmaceuticals
- Biomarin Pharmaceuticals
- Novartis
- F.Hoffmann-La Roche AG
- Johnson and Johnson
- Other Major & Niche Key Players

Timeline Considered for Analysis:

- 2015 to 2017 – Historical Year
- 2018 – Base Year
- 2019 – Estimated Year
- 2019 to 2024 – Forecasted Year

Customization: We also offers customization’s in the industry report as per the company’s specific needs.

Key Questions Answered in the Global Orphan Drugs Industry Report;

- What is the overall market size in 2018? What will be the market growth during the forecast period i.e. 2019-2024?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?

1. Preface

1.1. Research Methodology
1.1.1. Industry Research
1.1.2. Research Process and Design
1.1.2.1. Secondary Research
1.1.2.2. Key Sources and Use of Primary Research
1.1.2.3. Market Size Estimation and Forecast
1.1.2.4. Research Report
1.2. Geographic Scope
1.3. Years Considered
1.4. Key Deliverables of the Study
1.5. Assumptions and Limitations for Market Estimation and Forecasting

2. Executive Summary

2.1. Market Snapshot
2.2. Market Overview
2.3. CXO Perspective
2.4. Top Global Orphan Drugs Market Trends for 2019

3. Porter’s Five Force Analysis

3.1. Threat of Substitutes
3.2. Bargaining Power of Buyers
3.3. Bargaining Power of Suppliers
3.4. Threat of New Entrants
3.5. Degree of Competition

4. Manufacturing Cost Structure Analysis

4.1. Raw Material and Suppliers
4.2. Industry Chain Structure of Orphan Drugs Market
4.3. Manufacturing Process Analysis of Orphan Drugs Market
4.4. Manufacturing Cost Structure Analysis of Orphan Drugs Market

5. Manufacturing Plants Analysis of Orphan Drugs Market

5.1. Capacity and Production
5.2. Global Orphan Drugs Market Manufacturing Plants Distribution
5.3. Recent Development and Expansion Plans

6. Competitive Landscape

6.1. Global Orphan Drugs Market 2018
6.2. Global Orphan Drugs Market Value Share, By Company 2018
6.3. Global Orphan Drugs Market Volume Share, By Company 2018

7. Market Dynamics

7.1. Growth Drivers & Barriers in Orphan Drugs Market
7.1.1. North America
7.1.2. Europe
7.1.3. Asia Pacific
7.1.4. Rest of World
7.2. Opportunities in Orphan Drugs Market

8. Global Orphan Drugs Market

8.1. Introduction
8.2. Key Trends & Growth Drivers
8.3. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
8.4. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

9. Global Orphan Drugs Market Segmentation Analysis, By Disease Type

9.1. Introduction
9.2. Strategic Insights
9.2.1. BPS Analysis, By Disease Type
9.2.2. Market Attractiveness, By Disease Type
9.3. Hematologic and Immunologic diseases
9.3.1. Key Trends & Growth Drivers
9.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4. Infectious diseases
9.4.1. Key Trends & Growth Drivers
9.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5. Metabolic diseases
9.5.1. Key Trends & Growth Drivers
9.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.6. Neurologic diseases
9.6.1. Key Trends & Growth Drivers
9.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.7. Oncologic diseases
9.7.1. Key Trends & Growth Drivers
9.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
9.8. Other orphan diseases
9.8.1. Key Trends & Growth Drivers
9.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
9.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

10. Global Orphan Drugs Market Segmentation Analysis, By Product Type
10.1. Introduction
10.2. Strategic Insights
10.2.1. BPS Analysis, By Product Type
10.2.2. Market Attractiveness, By Product Type
10.3. Biological orphan drugs
10.3.1. Key Trends & Growth Drivers
10.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
10.4. Non-biological orphan drugs
10.4.1. Key Trends & Growth Drivers
10.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
10.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

11. Geographical Analysis

11.1. Introduction
11.2. North America Orphan Drugs Market
11.2.1. Key Trends & Growth Drivers
11.2.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4. By Disease Type
11.2.4.1. Introduction
11.2.4.2. Strategic Insights
11.2.4.2.1. BPS Analysis, By Disease Type
11.2.4.2.2. Market Attractiveness, By Disease Type
11.2.4.3. Hematologic and Immunologic diseases
11.2.4.3.1. Key Trends & Growth Drivers
11.2.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.4. Infectious diseases
11.2.4.4.1. Key Trends & Growth Drivers
11.2.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.5. Metabolic diseases
11.2.4.5.1. Key Trends & Growth Drivers
11.2.4.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.6. Neurologic diseases
11.2.4.6.1. Key Trends & Growth Drivers
11.2.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.7. Oncologic diseases
11.2.4.7.1. Key Trends & Growth Drivers
11.2.4.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.8. Other orphan diseases
11.2.4.8.1. Key Trends & Growth Drivers
11.2.4.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.4.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.5. By Product Type
11.2.5.1. Introduction
11.2.5.2. Strategic Insights
11.2.5.2.1. BPS Analysis, By Product Type
11.2.5.2.2. Market Attractiveness, By Product Type
11.2.5.3. Biological orphan drugs
11.2.5.3.1. Key Trends & Growth Drivers
11.2.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.5.4. Non-biological orphan drugs
11.2.5.4.1. Key Trends & Growth Drivers
11.2.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.6. By Country
11.2.6.1. Introduction
11.2.6.2. Strategic Insights
11.2.6.2.1. BPS Analysis, By Country
11.2.6.2.2. Market Attractiveness, By Country
11.2.6.3. U.S. Orphan Drugs Market
11.2.6.3.1. Key Trends & Growth Drivers
11.2.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.6.4. Canada Orphan Drugs Market
11.2.6.4.1. Key Trends & Growth Drivers
11.2.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.2.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

11.3. Europe Orphan Drugs Market
11.3.1. Key Trends & Growth Drivers
11.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4. By Disease Type
11.3.4.1. Introduction
11.3.4.2. Strategic Insights
11.3.4.2.1. BPS Analysis, By Disease Type
11.3.4.2.2. Market Attractiveness, By Disease Type
11.3.4.3. Hematologic and Immunologic diseases
11.3.4.3.1. Key Trends & Growth Drivers
11.3.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.4. Infectious diseases
11.3.4.4.1. Key Trends & Growth Drivers
11.3.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.5. Metabolic diseases
11.3.4.5.1. Key Trends & Growth Drivers
11.3.4.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.6. Neurologic diseases
11.3.4.6.1. Key Trends & Growth Drivers
11.3.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.7. Oncologic diseases
11.3.4.7.1. Key Trends & Growth Drivers
11.3.4.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.8. Other orphan diseases
11.3.4.8.1. Key Trends & Growth Drivers
11.3.4.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.4.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.5. By Product Type
11.3.5.1. Introduction
11.3.5.2. Strategic Insights
11.3.5.2.1. BPS Analysis, By Product Type
11.3.5.2.2. Market Attractiveness, By Product Type
11.3.5.3. Biological orphan drugs
11.3.5.3.1. Key Trends & Growth Drivers
11.3.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.5.4. Non-biological orphan drugs
11.3.5.4.1. Key Trends & Growth Drivers
11.3.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6. By Country
11.3.6.1. Introduction
11.3.6.2. Strategic Insights
11.3.6.2.1. BPS Analysis, By Country
11.3.6.2.2. Market Attractiveness, By Country
11.3.6.3. Germany Orphan Drugs Market
11.3.6.3.1. Key Trends & Growth Drivers
11.3.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.4. United Kingdom Orphan Drugs Market
11.3.6.4.1. Key Trends & Growth Drivers
11.3.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.5. France Orphan Drugs Market
11.3.6.5.1. Key Trends & Growth Drivers
11.3.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.6. Italy Orphan Drugs Market
11.3.6.6.1. Key Trends & Growth Drivers
11.3.6.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.7. Russia Orphan Drugs Market
11.3.6.7.1. Key Trends & Growth Drivers
11.3.6.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.8. Rest of Europe Orphan Drugs Market
11.3.6.8.1. Key Trends & Growth Drivers
11.3.6.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.3.6.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

11.4. Asia Pacific Orphan Drugs Market
11.4.1. Key Trends & Growth Drivers
11.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4. By Disease Type
11.4.4.1. Introduction
11.4.4.2. Strategic Insights
11.4.4.2.1. BPS Analysis, By Disease Type
11.4.4.2.2. Market Attractiveness, By Disease Type
11.4.4.3. Hematologic and Immunologic diseases
11.4.4.3.1. Key Trends & Growth Drivers
11.4.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.4. Infectious diseases
11.4.4.4.1. Key Trends & Growth Drivers
11.4.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.5. Metabolic diseases
11.4.4.5.1. Key Trends & Growth Drivers
11.4.4.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.6. Neurologic diseases
11.4.4.6.1. Key Trends & Growth Drivers
11.4.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.7. Oncologic diseases
11.4.4.7.1. Key Trends & Growth Drivers
11.4.4.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.8. Other orphan diseases
11.4.4.8.1. Key Trends & Growth Drivers
11.4.4.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.4.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.5. By Product Type
11.4.5.1. Introduction
11.4.5.2. Strategic Insights
11.4.5.2.1. BPS Analysis, By Product Type
11.4.5.2.2. Market Attractiveness, By Product Type
11.4.5.3. Biological orphan drugs
11.4.5.3.1. Key Trends & Growth Drivers
11.4.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.5.4. Non-biological orphan drugs
11.4.5.4.1. Key Trends & Growth Drivers
11.4.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6. By Country
11.4.6.1. Introduction
11.4.6.2. Strategic Insights
11.4.6.2.1. BPS Analysis, By Country
11.4.6.2.2. Market Attractiveness, By Country
11.4.6.3. China Orphan Drugs Market
11.4.6.3.1. Key Trends & Growth Drivers
11.4.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.4. India Orphan Drugs Market
11.4.6.4.1. Key Trends & Growth Drivers
11.4.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.5. Japan Orphan Drugs Market
11.4.6.5.1. Key Trends & Growth Drivers
11.4.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.6. South Korea Orphan Drugs Market
11.4.6.6.1. Key Trends & Growth Drivers
11.4.6.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.7. Indonesia Orphan Drugs Market
11.4.6.7.1. Key Trends & Growth Drivers
11.4.6.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.8. Taiwan Orphan Drugs Market
11.4.6.8.1. Key Trends & Growth Drivers
11.4.6.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.9. Australia Orphan Drugs Market
11.4.6.9.1. Key Trends & Growth Drivers
11.4.6.9.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.9.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.10. New Zealand Orphan Drugs Market
11.4.6.10.1. Key Trends & Growth Drivers
11.4.6.10.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.10.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.11. Rest of Asia Pacific Orphan Drugs Market
11.4.6.11.1. Key Trends & Growth Drivers
11.4.6.11.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.4.6.11.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

11.5. Latin America Orphan Drugs Market
11.5.1. Key Trends & Growth Drivers
11.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4. By Disease Type
11.5.4.1. Introduction
11.5.4.2. Strategic Insights
11.5.4.2.1. BPS Analysis, By Disease Type
11.5.4.2.2. Market Attractiveness, By Disease Type
11.5.4.3. Hematologic and Immunologic diseases
11.5.4.3.1. Key Trends & Growth Drivers
11.5.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.4. Infectious diseases
11.5.4.4.1. Key Trends & Growth Drivers
11.5.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.5. Metabolic diseases
11.5.4.5.1. Key Trends & Growth Drivers
11.5.4.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.6. Neurologic diseases
11.5.4.6.1. Key Trends & Growth Drivers
11.5.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.7. Oncologic diseases
11.5.4.7.1. Key Trends & Growth Drivers
11.5.4.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.8. Other orphan diseases
11.5.4.8.1. Key Trends & Growth Drivers
11.5.4.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.4.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.5. By Product Type
11.5.5.1. Introduction
11.5.5.2. Strategic Insights
11.5.5.2.1. BPS Analysis, By Product Type
11.5.5.2.2. Market Attractiveness, By Product Type
11.5.5.3. Biological orphan drugs
11.5.5.3.1. Key Trends & Growth Drivers
11.5.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.5.4. Non-biological orphan drugs
11.5.5.4.1. Key Trends & Growth Drivers
11.5.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.6. By Country
11.5.6.1. Introduction
11.5.6.2. Strategic Insights
11.5.6.2.1. BPS Analysis, By Country
11.5.6.2.2. Market Attractiveness, By Country
11.5.6.3. Brazil Orphan Drugs Market
11.5.6.3.1. Key Trends & Growth Drivers
11.5.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.6.4. Mexico Orphan Drugs Market
11.5.6.4.1. Key Trends & Growth Drivers
11.5.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.6.5. Rest of Latin America Orphan Drugs Market
11.5.6.5.1. Key Trends & Growth Drivers
11.5.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.5.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

11.6. Middle East & Africa Orphan Drugs Market
11.6.1. Key Trends & Growth Drivers
11.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4. By Disease Type
11.6.4.1. Introduction
11.6.4.2. Strategic Insights
11.6.4.2.1. BPS Analysis, By Disease Type
11.6.4.2.2. Market Attractiveness, By Disease Type
11.6.4.3. Hematologic and Immunologic diseases
11.6.4.3.1. Key Trends & Growth Drivers
11.6.4.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.4. Infectious diseases
11.6.4.4.1. Key Trends & Growth Drivers
11.6.4.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.5. Metabolic diseases
11.6.4.5.1. Key Trends & Growth Drivers
11.6.4.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.6. Neurologic diseases
11.6.4.6.1. Key Trends & Growth Drivers
11.6.4.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.7. Oncologic diseases
11.6.4.7.1. Key Trends & Growth Drivers
11.6.4.7.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.7.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.8. Other orphan diseases
11.6.4.8.1. Key Trends & Growth Drivers
11.6.4.8.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.4.8.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.5. By Product Type
11.6.5.1. Introduction
11.6.5.2. Strategic Insights
11.6.5.2.1. BPS Analysis, By Product Type
11.6.5.2.2. Market Attractiveness, By Product Type
11.6.5.3. Biological orphan drugs
11.6.5.3.1. Key Trends & Growth Drivers
11.6.5.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.5.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.5.4. Non-biological orphan drugs
11.6.5.4.1. Key Trends & Growth Drivers
11.6.5.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.5.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6. By Geography
11.6.6.1. Introduction
11.6.6.2. Strategic Insights
11.6.6.2.1. BPS Analysis, By Geography
11.6.6.2.2. Market Attractiveness, By Geography
11.6.6.3. GCC Orphan Drugs Market
11.6.6.3.1. Key Trends & Growth Drivers
11.6.6.3.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6.3.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6.4. North Africa Orphan Drugs Market
11.6.6.4.1. Key Trends & Growth Drivers
11.6.6.4.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6.4.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6.5. South Africa Orphan Drugs Market
11.6.6.5.1. Key Trends & Growth Drivers
11.6.6.5.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6.5.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6.6. Rest of Middle East & Africa Orphan Drugs Market
11.6.6.6.1. Key Trends & Growth Drivers
11.6.6.6.2. Historical Market Value 2015-2017, Market Value Forecast & Y-o-Y Growth Analysis, 2019-2024
11.6.6.6.3. Historical Market Volume 2015-2017, Market Volume Forecast & Y-o-Y Growth Analysis, 2019-2024

12. Company Profile

12.1. Market Share of Key Players in Orphan Drugs Market
12.2. Orphan Drugs Market Company Analysis
12.2.1. Actelion Pharmaceuticals Ltd.
12.2.1.1. Company Overview
12.2.1.2. Product Offered
12.2.1.3. Business Strategy
12.2.1.4. Financials
12.2.1.5. SWOT Analysis
12.2.1.6. Market Share Analysis
12.2.1.7. Key Achievements & Developments
12.2.2. Amgen
12.2.2.1. Company Overview
12.2.2.2. Product Offered
12.2.2.3. Business Strategy
12.2.2.4. Financials
12.2.2.5. SWOT Analysis
12.2.2.6. Market Share Analysis
12.2.2.7. Key Achievements & Developments
12.2.3. Alexion Pharmaceuticals
12.2.3.1. Company Overview
12.2.3.2. Product Offered
12.2.3.3. Business Strategy
12.2.3.4. Financials
12.2.3.5. SWOT Analysis
12.2.3.6. Market Share Analysis
12.2.3.7. Key Achievements & Developments
12.2.4. Baxter international
12.2.4.1. Company Overview
12.2.4.2. Product Offered
12.2.4.3. Business Strategy
12.2.4.4. Financials
12.2.4.5. SWOT Analysis
12.2.4.6. Market Share Analysis
12.2.4.7. Key Achievements & Developments
12.2.5. Bayer healthcare pharmaceuticals
12.2.5.1. Company Overview
12.2.5.2. Product Offered
12.2.5.3. Business Strategy
12.2.5.4. Financials
12.2.5.5. SWOT Analysis
12.2.5.6. Market Share Analysis
12.2.5.7. Key Achievements & Developments
12.2.6. Biomarin Pharmaceuticals
12.2.6.1. Company Overview
12.2.6.2. Product Offered
12.2.6.3. Business Strategy
12.2.6.4. Financials
12.2.6.5. SWOT Analysis
12.2.6.6. Market Share Analysis
12.2.6.7. Key Achievements & Developments
12.2.7. Novartis
12.2.7.1. Company Overview
12.2.7.2. Product Offered
12.2.7.3. Business Strategy
12.2.7.4. Financials
12.2.7.5. SWOT Analysis
12.2.7.6. Market Share Analysis
12.2.7.7. Key Achievements & Developments
12.2.8. F.Hoffmann-La Roche AG
12.2.8.1. Company Overview
12.2.8.2. Product Offered
12.2.8.3. Business Strategy
12.2.8.4. Financials
12.2.8.5. SWOT Analysis
12.2.8.6. Market Share Analysis
12.2.8.7. Key Achievements & Developments
12.2.9. Johnson and Johnson
12.2.9.1. Company Overview
12.2.9.2. Product Offered
12.2.9.3. Business Strategy
12.2.9.4. Financials
12.2.9.5. SWOT Analysis
12.2.9.6. Market Share Analysis
12.2.9.7. Key Achievements & Developments
12.2.10. Other Prominent Players

13. Disclaimer

Select License Type
  • Single User License $3750 USD
  • Multi-User License $4750 USD
  • Corporate User License $5750 USD

Request For Customization



Request Customization

Check Discount



Request Discount

Corporate Clients

More than 200 Clients